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Background: Patients’ perspectives provide valuable information on quality of care. This study evaluates the
feasibility and validity of Internet administration of Service Satisfaction Scale for Cancer Care (SCA) to assess patient
satisfaction with outcome, practitioner manner/skill, information, and waiting/access.
Patients and methods: Primary data collected from November 2007 to April 2008. Patients receiving cancer care
within 1 year were recruited from oncology, surgery, and radiation clinics at a tertiary care hospital. An Internet-based
version of the 16-item SCA was developed. Participants were randomised to Internet SCA followed by paper SCA 2
weeks later or vice versa. Seven-point Likert scale responses were converted to a 0–100 scale (minimum–maximum
satisfaction). Response distribution, Cronbach’s alpha, and test–retest correlations were calculated.
Results: Among 122 consenting participants, 78 responded to initial SCA. Mean satisfaction scores for paper/
Internet were 91/90 (outcome), 95/94 (practitioner manner/skill), 89/90 (information), and 86/86 (waiting/access).
Response rate and item missingness were similar for Internet and paper. Except for practitioner manner/skill, test–
retest correlations were robust r = 0.77 (outcome), 0.74 (information), and 0.75 (waiting/access) (all P < 0.001).
Conclusions: Internet SCA administration is a feasible and a valid measurement of cancer care satisfaction for
a wide range of cancer diagnoses, treatment modalities, and clinic settings.
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background
Despite advances in cancer detection and treatment, many
patients perceive deﬁciencies in cancer care quality [1–4],
deﬁned as ‘the degree to which health services for individuals or
populations increase the likelihood of desired health outcomes’
[5, 6]. Although cancer care quality can be evaluated from
multiple perspectives (patient, provider, insurer, etc.), patients
have been proposed as the ultimate arbiter of care quality [7].
Patients’ perspectives on cancer care processes and outcomes
provide unique and valuable information about the quality of
care. However, cancer care quality assessments generally
depend on medical claims data or medical records abstraction
and do not directly assess the cancer care from the patient’s
perspective [8].
The three components of health care satisfaction are
satisfaction with (i) structure (e.g. organisation, accessibility),
(ii) process (e.g. technical and interpersonal competence of the
provider), and (iii) outcome (e.g. satisfaction with overall
perceived maintenance of health) [9]. However, most previous
assessments of cancer care patient satisfaction focus only on
health care structure and process [10–19].
We previously developed a novel instrument, the Service
Satisfaction Scale for Cancer Care (SCA), to evaluate all three
dimensions of patient satisfaction with cancer care (process,
structure, and outcome) and validated it in a sample of
urological cancer survivors and their spouse partners [20]. The
SCA consists of 16 items and is derived from a factor-based
reduced form of the Services Satisfaction Scale (SSS-30) [21, 22].
The SSS-30 scale distributions show lower ceiling effects and less
skew than a competing satisfaction measure, the Client
Satisfaction Questionnaire-8 [22]. Developed as a self-reported
paper instrument, the SCA evaluates patient satisfaction in four
care domains on a 7-point Likert scale: (i) outcome of cancer
care, (ii) care provider manner and skill, (iii) information
provided about care, and (iv) waiting time/access to care. In
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demonstrated that changes in quality of life were signiﬁcantly
associated with patient (and partner) satisfaction with treatment
outcome [2]. However, the SCA has not been assessed for
patients with nonurological cancers and with alternative modes
of survey administration. In the current study, we (i) assessed the
feasibility and performance of the SCA for a wide range of
cancers and (ii) determined the validity of an Internet-based
version of the SCA. Electronic surveys may facilitate efﬁcient
data collection, improve the convenience of questionnaire
completion [13, 23], and increase item responses [23, 24].
patients and methods
study population and design
We developed an Internet-based version of the SCA using the exact wording
and scale of the validated paper version. A secure password-protected
Universal Resource Locator [25] was created to allow anonymous survey
access. Item responses were recorded via a ‘drop-down’ box, which
represented the 7-point Likert scale (from 1 to 7: completely satisﬁed, very
satisﬁed, somewhat satisﬁed, mixed, somewhat unsatisﬁed, very unsatisﬁed,
and completely unsatisﬁed) (Appendix 1). Responses were stored on a secure
Web server accessible only to the study staff. A four-digit subject identiﬁcation
number was used to match paper and Internet survey responses.
With approval from the Beth Israel Deaconess Medical Center (BIDMC)
Institutional Review Board, potential participants were identiﬁed through
a review of online medical records of patients seen by 21 participating
providers in medical, surgical, gynaecological, and radiation oncology
clinics at BIDMC from November 2007 to April 2008. Providers could
decline participation on behalf of individual patients. To conﬁrm eligibility,
a research assistant not afﬁliated with clinics nor involved in patient care
approached all consecutive potentially eligible participants for each clinic
date. Eligible patients were all English-speaking adults who had completed
at least one standard cancer therapy (surgery, chemotherapy, and/or
radiation therapy) within the past year for any cancer of any stage. The
exclusion criteria were no computer/Internet access outside of the clinic.
Active cancer treatment at the time of screening did not qualify as
a completed cancer treatment course but was not an exclusion criterion.
Of 254 potential participants approached, 155 met all eligibility criteria.
The eligibility status of 10 participants could not be determined and were
considered ineligible (Figure 1). After eligibility veriﬁcation, potential
participants were provided a written informed consent form to review and
were invited to sign if they wished to participate.
Consenting participants were randomly assigned to one of two groups.
The ‘Internet First’ group was asked to complete the Internet-based survey
at home within 2 weeks of study enrolment and was given written
instructions to access the survey. Two weeks after completion of the
Internet-based survey, a self-administered paper survey was mailed to the
subject, with instructions to complete and return the survey by mail
Figure 1. Participant enrolment ﬂowchart.
*One participant with mutually exclusive responses to all items on the paper and Internet surveys was considered noninformative and was excluded from all
analysis.
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self-administered paper survey at home within 2 weeks of study enrolment
and was given a paper copy of the survey. Upon receipt of the paper survey,
instructions for accessing the Internet-based survey at home were mailed to
the patient, with a request to complete the Internet-based survey within 2
weeks. Participants were provided a preaddressed and stamped envelope in
which to return the paper survey. Participants received a telephone
reminder call if the survey was not completed within 2 weeks, a time period
associated with higher response rates for health-related quality of life
(HRQoL) surveys [26].
measures and statistical analyses
Baseline demographics, cancer diagnosis, cancer stage, and treatment
modalities were compared between the two randomised groups. Individual
items responses were linearly converted from a 7-item Likert scale to a 0–
100 scale (higher scores representing higher satisfaction) for item analysis.
For domain analysis, Likert scale raw item scores were summed and
averaged to create a raw Likert domain score. The domain score was then
linearly converted to a 0–100 linear scale. All available responses were
included for item and domain scores except as noted.
The responses of all participants who completed at least one survey were
analysed in order to compare the paper and Internet survey responses and
to evaluate the internal consistency of each survey version. For each
satisfaction domain, only those participants answering >65% of items
within the domain were analysed. Participants who did not meet the
minimum response criteria for a domain were excluded from analysis for
that domain. The mean score and standard deviations for individual items
and for each satisfaction domain were calculated separately for (i) paper
surveys alone, (ii) Internet surveys alone, and (iii) all surveys. To evaluate
the presence of a ceiling effect in the SCA, the percentage of participants
scoring the maximum (100) on each item and domain was calculated. In
order to evaluate internal consistency, Cronbach’s alpha was calculated for
each domain using SAS version 9 (SAS Institute Inc., Cary, NC).
To assess the validity of the Internet-based SCA, we conducted test–retest
analysis for each satisfaction domain for all participants completing both
surveys. Intraclass correlation coefﬁcients were calculated and statistical
signiﬁcance was determined by conﬁdence intervals using Fisher’s z
transformation. A P value of <0.05 was considered statistically signiﬁcant.
Analyses were performed using SAS version 9 and SigmaPlot software
(Systat, San Jose, CA).
One participant with mutually exclusive responses to all items on the
paper and Internet surveys was considered noninformative and was
excluded from all analysis. In addition, we performed a graphical inspection
of the linear regression plots during the test–retest analysis in order to
identify participants whose responses changed drastically between the paper
and Internet surveys. A single participant identiﬁed with disparate
responses was included in the overall analysis but was excluded from the
exploratory test–retest correlation analysis.
results
study population
Of 122 consenting participants, 78 (64%) completed the initial
survey. The mean age (59 years; range 30–80), sex, and race
(>90% Caucasian) were well balanced between the two
randomised groups (Table 1). Participants were diagnosed with
a wide range of cancer types (breast, lung, gastrointestinal,
genitourinary, gynaecological, haematological, and skin) and all
stages (localised, locally advanced, recurrent, and metastatic)
were represented. Although breast and lung cancers were the
most common diagnoses in both groups, cancer diagnoses were
fairly well balanced between the two groups. More than 50% of
participants in each group were undergoing chemotherapy at
the time of study participation.
satisfaction with cancer care
For completed paper and Internet surveys, mean scores for all
16 questions ranged from 82 to 96, on a scale from 1 to 100.
The highest mean domain score (paper, Internet) was manner/
skill (94, 95), followed by outcome (91, 90), information (89,
90), and waiting/access (86, 86) (Table 2). Each domain score
showed internal consistency (Cronbach’s alpha ‡0.80), except
the Internet survey provider manner/skill and waiting/access to
care domains (Cronbach’s alpha = 0.69 and 0.62, respectively).
For participants who completed both versions of the survey
instrument, test–retest analysis showed signiﬁcant correlations
(r = 0.48–0.78; P < 0.05) in all four satisfaction domains.
Outcome, waiting/access, and information domains had similar
intraclass correlation levels when evaluated as a group and by
subgroup (r = 0.74–0.77) (Table 2). Ordering (Paper First
versus Internet First) did not signiﬁcantly change these results.
The manner/skill domain for the Paper First group produced
the weakest correlation (r = 0.48; P < 0.05). Graphical
Table 1. Characteristics of participants who completed initial survey
(n = 77)
Demographic items Internet First
%( n)
Paper First
%( n)
Total (38)
a (39)
Mean age (standard deviation) 59 (9.2) 59 (10.1)
Female 58 (22) 59 (23)
% Caucasian 97.4 (37) 94.9 (37)
Cancer diagnosis
Breast 31.6 (12) 28.2 (11)
Lung 18.4 (7) 25.6 (10)
Gastrointestinal
b 15.8 (6) 20.5 (8)
Kidney 10.5 (4) 10.3 (4)
Prostate 10.5 (4) 5.1 (2)
Ovarian 5.3 (2) 7.7 (3)
Other
c 7.9 (3) 2.6 (1)
Cancer status
Localised 55.3 (21) 35.9 (14)
Locally advanced/advanced 5.2 (2) 7.7 (3)
Metastatic/recurrent 39.5 (15) 56.4 (22)
Treatment
Single modality
Surgery only 31.6 (12) 20.5 (8)
Chemotherapy only 23.7 (9) 17.9 (7)
Multiple modalities
Surgery 6 radiation
and/or chemo
34.2 (15) 53.8 (21)
Radiation and chemotherapy 10.5 (4) 7.7 (3)
aOne participant with mutually exclusive responses to all items on the paper
and Internet surveys was considered noninformative and was excluded
from all analysis.
bGastrointestinal cancer: oesophageal, colon, pancreatic, rectal, and
cholangiocarcinoma.
cOther cancers: melanoma, thymoma, multiple myeloma, and endometria
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revealed one subject with a substantial change in response for
the manner/skill domain between the two surveys. Exploratory
analysis excluding this potential outlier improved the test–
retest correlation for this domain (Paper First, r = 0.81, 95%
conﬁdence interval = 0.59–0.91 and combined, r = 0.72, 95%
conﬁdence interval = 0.56–0.83).
Of 78 participants completing the ﬁrst version of the survey,
54 (69%) completed the retest survey. The proportion of
participants who completed the retest was higher for those who
completed the Internet survey ﬁrst than for those who
completed the paper survey ﬁrst: 32 of 39 (82%) versus 22 of 39
(56%), respectively. The mean time between initial consent and
completion of the ﬁrst survey was 16.7 days (Paper First = 21.5
days and Internet First = 11.9 days). The mean time between
completion of the ﬁrst and second surveys was 26.4 days (Paper
First = 30.6 days and Internet First = 23.6 days) (Figure 2).
A ceiling effect was apparent for all four domains in both
surveys, but a ﬂoor effect was not present (Figure 2). The
percent of responses at the ceiling were lowest for ‘waiting time
at appointment’ (Question 6) for both Internet (23%) and
paper (33%) and highest for ‘protected rights of patient’
(Question 9) for both Internet (77.1%) and paper (69%). The
average percent of responses at the ceiling was similar in both
the Internet and the paper SCA: 56% and 55%, respectively.
The number of missing item responses in paper and Internet
surveys was similar and the majority of items had zero missing
responses (Table 2; item missingness range = 0–15% per item
and overall item missingness = 1% for paper and 1.2% for
Internet versions). The proportion of scorable subscales (less
than one missing subscale item i) was 97.2% (paper) and 100%
(Internet) for outcome, 100% (paper) and 100% (Internet) for
practitioner, 100% (paper) and 100% (Internet) for access, and
100% (paper) and 100% (Internet) for information subscales.
Table 2. Comparison of satisfaction with cancer care (SCA) administered on paper versus Internet
Satisfaction
domain
question (Q)
a
Short description Mean score
(standard deviation)
Score
range
Cronbach’s
alpha
Intraclass
correlation
b
Paper Internet Paper Internet Paper Internet Paper Internet Both
Outcome 91 (10) 90 (10) 63–100 63–100 0.90 0.85 0.78 0.74 0.77
Q1 Help to deal with cancer 93 (10) 88 (15) 67–100 17–100
Q8 Prevent recurrence/progression 84 (17) 84 (18) 50–100 33–100
Q10 Quality of care 93 (10) 94 (9) 67–100 67–100
Q13 Relieve/prevent symptoms 89 (13) 88 (14) 50–100 33–100
Q16 Overall satisfaction 92 (11) 92 (9) 67–100 67–100
Manner/skill 94 (8) 95 (7) 73–100 60–100 0.87 0.69 0.48 0.65 0.55
Q2 Professional knowledge 94 (8) 95 (13) 67–100 17–100
Q3 Listening and responding 93 (10) 95 (9) 50–100 67–100
Q4 Personal manner 93 (11) 92 (16) 50–100 0–100
Q9 Conﬁdentiality 95 (8) 96 (7) 67–100 83–100
Q14 Thoroughness 93 (9) 95 (8) 67–100 83–100
Information 89 (11) 90 (12) 50–100 61–100 0.85 0.91 0.74 0.75 0.74
Q11 Availability of information 87 (15) 87 (14) 33–100 50–100
Q12 Explanations of treatments 91 (12) 92 (11) 50–100 67–100
Q15 Helpfulness of information 90 (11) 90 (13) 67–100 50–100
Waiting/access 86 (13) 86 (10) 44–100 61–100 0.80 0.62 0.74 0.75 0.74
Q5 Lag time after appt request 88 (15) 88 (13) 33–100 33–100
Q6 Wait after arrival 82 (16) 82 (14) 50–100 50–100
Q7 Availability of appt time 87 (15) 87 (13) 33–100 50–100
Italicized numbers are domain results.
Both = Internet-based and paper SCA (n = 131); paper = paper SCA (n = 70); Internet = Internet-based SCA (n = 61); Appt = Appointment.
aSee Appendix for details of each satisfaction domain question.
bCorrelation of paper and Internet survey responses of participants who completed both surveys.
SCA, Service Satisfaction Scale for Cancer Care.
Figure 2. Comparison of paper (P) versus Internet (I) surveys (all
participants)—lower boundary of the box represents 25th percentile—line
within the box represents median—upper boundary of the box represents
75th percentile—whiskers above and below the box represent 90th and
10th percentiles, respectively—points represent outliers.
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was the same for both Internet and paper surveys (‘What is
your overall feeling about the effect of your cancer treatment in
preventing cancer progression and recurrence?’) (paper = seven
missing responses and Internet = nine missing responses)
(Table 2 and Figure 2).
conclusions
Our study establishes the feasibility and validity of the SCA for
assessment of patient satisfaction with cancer care outcome,
process, and structure via paper- or Internet-based
administration. The four SCA satisfaction domains
demonstrated test–retest reliability, internal consistency, and
validity for the paper- and Internet-based version. These
ﬁndings support the use of the SCA version most appropriate
for the study population. To our knowledge, this study is the
ﬁrst to validate an electronic instrument that comprehensively
measures satisfaction with cancer care outcome (in addition to
cancer care process and structure) for patients with a wide
range of tumour types and stages [10–12, 15–19, 27].
The validation results of our study are supported by a meta-
analysis demonstrating that electronic and paper
administration of patient reported outcome instruments yield
equivalent results [10, 28–31]. The only electronic evaluation of
satisfaction with cancer care (SEQUS for medical oncology
outpatients) only evaluates structure and process but not
outcome. The top concern identiﬁed by SEQUS [10] (patient
waiting times) was also determined to be an area of relative
dissatisfaction in our study. However, additional satisfaction
with outcomes data from our study places this result in context,
potentially informing resource allocation decisions that
optimally improve cancer care quality.
The results of our study must be considered in contexts of its
limitations. Due to loss of follow-up, 64% of consented patients
completed the initial survey and 44% completed both surveys.
However, this completion rate is consistent with other
evaluations of patient satisfaction with cancer care (50%–
100%) [10–12, 14, 16, 17].
The relatively small sample size and the single urban
academic institution study population did not permit subset
evaluation and may limit generalisability of to other settings.
However, the results of our study for a wide range of cancer
diagnoses are consistent with a larger paper SCA study of
patients with prostate cancer at multiple institutions across
the United States [2]. Additionally, due to the test–retest study
design for the study hypothesis, patients who were unable to
use or access a computer with Internet were excluded. Our
results, therefore, may have demographic, socioeconomic,
and/or functional status biases. However, others have
demonstrated validity of electronic HRQoL surveys for a wide
range of patients with varying levels of computer literacy,
education, age, sex, and race [13, 28, 32]. In addition, the off-
site design was chosen to minimise positive bias associated
with on-site surveys [33]. Finally, we designed this study to
closely mirror real-life situations of future quality
improvement or research situations without on-site
computer/Internet access and in-person assistance for
respondents.
A ceiling effect was present for both versions of the survey, as
commonly seen in patient satisfaction surveys [34–36]. Ceiling
effects may reﬂect prior ﬁndings that survey responders have
more positive experiences than nonresponders [37] and may
obscure the true magnitude of satisfaction differences [35].
However, the majority of responses for all domains in both
surveys were less than the maximum score, indicating that the
survey instrument can discriminate the level of patient
satisfaction.
On average, the Paper First group had a longer time interval
between initial consent and completion of the ﬁrst survey and
between the completion of the ﬁrst and second surveys than the
Internet First group. This difference may be due to the longer
mailing times required for returning the paper survey and
receiving Internet survey instructions and may account for the
higher attrition rate for the Paper First group. A previous study
found higher response rates among cancer patients who
received a satisfaction survey more quickly [26]. Although the
completion time interval difference may have affected survey
values, the presence of robust test–retest correlations suggests
minimal effect on validity testing.
To assess for potential response bias, we performed
exploratory chart reviews of patients with missing responses for
the question with the highest number of missing responses (n =
13): ‘What is your overall feeling about the effect of your cancer
treatment in preventing cancer progression and recurrence?’
Participants with missing responses tended to be undergoing
active cancer treatment (n = 7), have metastatic or recurrent
cancer (n = 7), and/or symptoms secondary to cancer or cancer
treatment complications (n = 5). These may be situations in
which nonresponders felt uncertain about their prognosis.
As a validation study, this study did not assess patient
preferences for survey version nor the impact of the Internet-
based instrument on practice patterns. Several studies
demonstrate that electronic collection of patient reported data
facilitates real-time feedback of survey results to clinicians and
may confer several advantages [29, 34, 38, 39]: (i) increased
clinician inquiries about HRQoL issues [34, 38], (ii) improved
clinician-perceived communication with patients [38], and (iii)
increased clinician-perceived tracking of HRQoL changes over
time [38].
Patient satisfaction may vary due to factors beyond the
current care provider’s control, including the limitations of
current cancer treatments [27, 36, 40–43]. Further study is also
needed on how patient satisfaction data affects the patient–
provider relationship, particularly in cancer care where both the
provider and the patient may be disappointed with the
effectiveness of current therapies. Currently, some health payers
provide ﬁnancial incentives for cancer care quality
improvement based on patient satisfaction data [44].
Assessment of satisfaction with outcome, such as provided by
the SCA, may highlight important gaps in quality, including
those due to socioeconomic disparities [1]. However, the effect
of these ﬁnancial incentives on patient outcome is unknown.
Cancer care quality assessment instruments that assess
satisfaction with outcome may be important to answer these
questions and generate new hypotheses.
In conclusion, our study demonstrates that the paper and
Internet-based versions of the SCA provide valid measures of
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including treatment outcome, and may be useful for evaluating
cancer care quality for a variety of cancer diagnoses, clinical
settings, and treatment modalities. Multiple options for patient
satisfaction survey completion (self-completion with a paper or
Internet version at home or in the clinic, in-person completion,
or over the telephone) may enhance patient response rates and
diversity. The SCA may help improve cancer care quality by
placing other metrics of patient satisfaction in context with
cancer treatment outcome.
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appendix 1. SCA survey questions
What is your overall feeling about the .
1. Effect of health care services in helping you deal with your cancer
and maintain your well being?
2. Professional knowledge and competence of your main cancer
practitioner(s)?
3. Ability of your main cancer practitioner(s) to listen and respond to
your concerns or problems?
4. Personal manner of the main cancer practitioner(s) seen?
5. Waiting time between asking to be seen or treated and the
appointment given?
6. Waiting time when you come for an appointment?
7. Availability of appointment times that ﬁt your schedule?
8. Effect of cancer treatment in preventing cancer progression or
recurrence?
9. How well your conﬁdentiality and rights as an individual have been
protected?
10. Quality of cancer care you have received?
11. Availability of information on how to get the most out of the
cancer care and related services?
12. Explanations of speciﬁc procedures and treatment approaches
used?
13. Effect of services in helping relieve symptoms of reduce
problems?
14. Thoroughness of the main cancer practitioner(s) you have
seen?
15. Helpfulness of the information provided about your cancer and its
treatment?
16. In an overall general sense, how satisﬁed are you with the cancer
treatment you have received?
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